Reply To: Traders Market Weekly: Liberty Dichotomy; Paris Burns Ahead of Independance Day

#61070
Truman
Participant

Pfizer (PFE 37.45, -0.90, -2.4%): is continuing to advance the first full agonist oral GLP-1-RA candidate danuglipron toward late-state development, Second GLP-1-RA candidate lotiglipron to be discontinued